Rare diseases
Investigational molecules
Locations
Via Nicolo' Giustiniani 2, 35128 Padua, Italy
Azienda Ospedaliera di Padova in Padua, Italy specialises in clinical trials of conditions such as Colitis ulcerative, Chronic lymphocytic leukaemia, Hereditary angioedema, Crohn's disease, and other specialisations. This site conducts important research.
The medical center is at the forefront of research in gastroenterology and hepatology, focusing on innovative treatments for conditions such as ulcerative colitis and alcohol-related liver disease.
Through rigorous clinical trials, the center is advancing therapeutic options that aim to improve patient outcomes and quality of life.
Specializing in dermatology and wound care, the center is pioneering research into novel skin graft products for treating full-thickness skin defects.
These advancements are crucial for enhancing healing processes and minimizing scarring in patients with significant skin injuries.
The center is a leader in nephrology research, focusing on conditions like C3 glomerulopathy and lupus nephritis.
By exploring new treatment modalities, the center aims to improve renal function and patient survival rates.
In the field of oncology, the center is conducting groundbreaking research on langerhans cell histiocytosis and choroidal melanoma.
These studies are pivotal in developing targeted therapies that aim to reduce mortality and improve long-term outcomes.
The center excels in cardiology research, particularly in managing coronary artery disease and calcific aortic valve stenosis.
Innovative diagnostic and therapeutic approaches are being developed to enhance cardiovascular health and patient care.
Focusing on neurology, the center is advancing research in Parkinson's disease and amyotrophic lateral sclerosis.
These efforts are directed towards developing therapies that slow disease progression and improve neurological function.
Clinical trials currently enrolling participants at this site.
Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
ItalyEvaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus
ItalyLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
ItalyA study to evaluate the effectiveness and safety of pridopidine hydrochloride in patients with amyotrophic lateral sclerosis
ItalyA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
ItalyA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
ItalyA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
ItalyA study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
ItalyA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
ItalyA study of navenibart for long-term safety in patients with hereditary angioedema
ItalyA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
ItalyA study testing duvakitug for patients with moderately to severely active ulcerative colitis
ItalyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
